Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Sona Nanotech Inc C.SONA

Alternate Symbol(s):  SNANF

Sona Nanotech Inc. is a nanotechnology life sciences company, which is engaged in developing targeted hyperthermia therapy. The Company has developed multiple methods for the manufacturing of various types of gold nanoparticles (GNR). It is engaged in research and development of its technology for use in multiplex diagnostic testing platforms and advanced biomedical applications. Its gold nanotechnologies are adapted for use in applications, as a safe and delivery system for multiple medical treatments, for the approval of various regulatory boards, including Health Canada and the Food and Drug administration (FDA). Its gold nanorod particles are manufactured without the use of cetyltrimethylammonium bromide (CTAB), eliminating the toxicity risks associated with the use of other gold nanorod technologies in medical applications. The Company is focused on the development of a pre-clinical nanomedical therapy for the treatment of cancer using its biocompatible GNR.


CSE:SONA - Post by User

Bullboard Posts
Post by Sandblaster1980on Aug 22, 2020 4:22pm
288 Views
Post# 31442180

In Vitro

In Vitrohttps://www.biospace.com/article/medical-device-technologies-market-in-vitro-diagnostic-devices-dominate-device-type-segment-due-to-rising-incidence-of-infectious-diseases/


Medical Device Technologies Market: In Vitro Diagnostic Devices Dominate Device Type Segment due to Rising Incidence of Infectious Diseases

According to a recent report compiled by Transparency Market Research (TMR), the competitive landscape of the global medical device technologies market is estimated to show remarkable growth owing to the technological advancements in the health and medical sector. The technological advancements used in medical gadgets has ensured a notable development in terms of treating illness and diagnosing them.

Some of the major players of the global medical device technologies market are Baxter International Inc., Boston Scientific Corporation, Johnson & Johnson, Medtronic plc, and Smith & Nephew plc. The market is mostly dominated by companies manufacturing in vitro diagnostic devices as they hold the maximum revenue share of the market. Nevertheless, small players are leaving no stone unturned in order to secure their place in the market worldwide.

Request Brochure of Report - https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=11705

As per the TMR report, the global medical device technologies market is anticipated to earn US$563.8 bn by the end of 2025. The market is estimated to expand with a CAGR of 4.6% within the forecast period of 2017 to 2025. Based on end user, academics and hospitals and research segment is seen to be leading the market share. From a geographical perspective, the market is seen to be dominated by North America followed by Europe.



Bullboard Posts